FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FUSN is currently covered by 6 analysts with an average price target of $21.76. This is a potential upside of $0.21 (0.97%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 7 price targets and 24 ratings on display. The stock rating distribution of FUSN is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 253 days.

Highest price target for FUSN is $21, Lowest price target is $3, average price target is $13.8.

Most recent stock forecast was given by YUAN ZHI from B. RILEY on 20-Mar-2024. First documented stock forecast 21-Jul-2020.

Currently out of the existing stock ratings of FUSN, 12 are a BUY (80%), 3 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$13

$-8.55 (-39.68%)

$13

1 years 15 days ago
(20-Mar-2024)

3/4 (75%)

$-8.09 (-38.36%)

287

Hold

$16

$-5.55 (-25.75%)

$16

1 years 15 days ago
(20-Mar-2024)

1/2 (50%)

$-5.09 (-24.13%)

15

Hold

$11

$-10.55 (-48.96%)

$10

1 years 16 days ago
(19-Mar-2024)

1/2 (50%)

$-10.18 (-48.06%)

496

Buy

$13

$-8.55 (-39.68%)

$13

1 years 2 months 9 days ago
(26-Jan-2024)

2/3 (66.67%)

$2.11 (19.38%)

131

Buy

$16

$-5.55 (-25.75%)

$15

1 years 2 months 30 days ago
(05-Jan-2024)

4/4 (100%)

$7.65 (91.62%)

143

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 253 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 19 price targets and 11 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

John Walsh with highest potential upside - $0

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison with lowest potential downside - -$11.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?